Find a TenderPlanned procurementPipeline notice

Published 10 Nov 2026, 16:28 GMT

Official UK procurement notice

NHS National Framework for Romiplostim

Official notice

Competition analysis

Authority: NHS England (NHS & healthcare)

Framework agreementGoodsOpen procedureAbove thresholdSME suitable

Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)East Midlands (UKF)

+4 more

West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)

Planned pipeline value£50,400,000pipeline notice, not a live tender

Tender notice expected 4 May 2027from the planned procurement notice

Framework period 1 yrends 31 Dec 2028 · up to 31 Dec 2030 with extensions · starts 1 Jan 2028

Notice summaryFrom the published notice

Project title: NHS National Framework for Romiplostim. Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team.

What is being bought

Published requirement description

Project title: NHS National Framework for Romiplostim

Offer reference number: CM/TNS/26/5769

Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team.

Please email [email protected], [email protected], [email protected] and [email protected]

CPV: Pharmaceutical products

How this framework works

From the published notice

Framework period: 1 yr · up to 3 yrs from 1 Jan 2028

The lotProcurement structure

single lot · no lot value published

Lot #1PlannedRenewal 1 yrSME

Contract period: 1 Jan 2028 – 31 Dec 2028 (1 yr) · up to 31 Dec 2030 with extensions

Delivery: North East, North West, East Midlands, West Midlands, East of England, South East, South WestEligibility: SME eligible

Extensions: Extension options published

33600000 Pharmaceutical products

Who is likely to bid for this lot ↓

What it takes to win
i

Evaluation split and conditions of participation as published; the tender pack may add more

What this means for your bid

“NHS National Framework for Romiplostim” is a framework: the contest is a place on its panel, not a single contract.

Pipeline intelligence · planning stage: how this market runs before the tender is published

How NHS England buys Pharmaceutical products (CPV 3360), and who usually turns up

NHS England’s published record next to the market for the same work. Compared with other frameworks and DPS only. Whole-market view: Pharmaceutical products (CPV 3360) →

How the contest usually goes

Winner shares use published awards; bid and price charts use contested lots.

Question for the bid

This buyerNHS England · division 33

The marketPharmaceutical products (CPV 3360) · UK-wide

What to do with it

How often do SMEs win?

The counts under this question show how many awards have a known supplier size.

Buyer: 149 of 507 known-size awards · market: CPV 3360 · UK-wide, n=366

29%25%

Small firms have won here. Neither number says whether you qualify; it describes who has been winning. 366 known-size awards sit across 37 procurements, so one procurement can dominate this percentage.

How often do local suppliers win?

Local means the winner is registered in the region where that award was delivered.

Buyer: 0 of 1 known-location awards · market: CPV 3360 · UK-wide, n=66

0 of 118%

Most of this buyer’s recorded winners were registered outside the region where that award was delivered.

How long to a decision?

Buyer: 26 decided notices · market: CPV 3360 · UK-wide, n=34

27 days30 days

Half of these awards have an award date within 27 days of the bid deadline.

How often single-bid or direct?

Both shares are minimums: some awards have no bid count.

Buyer: at least 0 of 30 procurements with awards had no recorded rival · market: CPV 3360 · UK-wide, n=37

0%27%

Missing bid counts may hide more single-bid awards. This share is a minimum.

How many bids did past lots attract?

This buyer90 lots with bid counts · broad CPV 33

16% had one bid

The market56 lots with bid counts · CPV 3360 · UK-wide

14% had one bid

% of lots with a published bid count: this buyer (90) / the market (56) · select a colour for counts

1 bid16% / 14%

Buyer: 14 of 90 lots with published bid counts. Market: 8 of 56 lots with published bid counts.

2–321% / 16%

Buyer: 19 of 90 lots with published bid counts. Market: 9 of 56 lots with published bid counts.

4–617% / 30%

Buyer: 15 of 90 lots with published bid counts. Market: 17 of 56 lots with published bid counts.

7+47% / 39%

Buyer: 42 of 90 lots with published bid counts. Market: 22 of 56 lots with published bid counts.

How did awards compare with estimates?

On a framework or DPS, prices are agreed when work is called off.

Not comparable on a framework or DPS: the price is set later, on each call-off.

Assess each lot
i

Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list

Our matching links this notice to “NHS Framework Agreement for Branded Medicines – National” and “NHS Framework Agreement for Branded Medicines - National Tender” of this authority, but none of the 15 panel members sit in a category matching this notice.

Lot #1CPV 336012 monthsSME suitablePublished estimate£50m

Expected competition

Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 56 past lots.

—No model forecast yet14% chance of a single bid

Past bids on 56 similar lots

1 bid14%

8 of 56 similar past lots received 1 bid (14%).

2–316%

9 of 56 similar past lots received 2–3 (16%).

4–630%

17 of 56 similar past lots received 4–6 (30%).

7+39%

22 of 56 similar past lots received 7+ (39%).

Comparable past lots usually drew 5 bids.

Commercial price forecast

No comparable awards for this lot yet.

—Priced at call-off

On a framework or DPS the price is agreed on each call-off, so there is no award price to forecast here: the published figure is a ceiling.

Who has supplied this buyer on similar work?
i

Supplier	This buyer’s earlier contract	Lot	Award value	Why listed
BiogenEarlier contract	CM/PHR/23/5701- NHS National Framework for Natalizumab-February 2024 ended Aug 2025	—	—	Matched as the earlier contract
Thornton and Ross LtdEarlier contract	CM/TNS/24/5719 - NHS National Framework for the supply of Pomalidomide ended May 2026	—	—	Matched as the earlier contract
Biocon Pharma UK LtdEarlier contract	NHS National Framework for Transition products commencing 1 February 2025ended May 2026	—	—	Matched as the earlier contract
LogixX Pharma LtdEarlier contract	NHS National Framework for Transition products commencing 1 May 2024ended Sept 2025	Apixaban, Sapropterin	—	Matched as the earlier contract
Immedica Pharma ABEarlier contract	NHS National Framework for Transition products commencing 1 May 2024ended Sept 2025	Dimethyl fumarate, Teriflunomide, Trabectedin	—	Matched as the earlier contract

Who could compete for this lot?
i

Candidate suppliers for this notice have not been worked out yet, so this is not a verdict that nobody fits.

About this data

Estimates, labelled. The price range, possible competitors and earlier-work matches are our estimates from past awards, not published facts, win chances or price advice. The buyer’s own record and the wider market are shown apart, never mixed.
Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.

Coming up in this sector

Contracts ending within 12 months · Retender Radar, sector filter set

Contracts ending in Medical Devices & PharmaRetender Radar, CPV 33: incumbents and end dates for the next 12 months

Procedure terms & legal framework

From the official record

Procedure method: Open procedure
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Procurement category: Goods
Notice status: Planned procurement
Procurement threshold: Above threshold (FTS publication)
Regulatory regime: Standard
Commercial structure: Framework agreement
Who may use this agreement: Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type: Competitive procedure
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 10 Nov 2026, 16:28 GMT
Last source update: 10 Nov 2026, 16:28 GMT
Authority reference: CM/TNS/26/5769
FTS notice number: 2026/S 000-106851
Latest notice: Pipeline notice (UK1)
Classification (CPV): Pharmaceutical products
Delivery area: North East (UKC)North West (UKD)East Midlands (UKF)West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Official registry OCID: ocds-h6vhtk-07b8f6 Find a Tender

How it was run

Official notice

Appointment period ends: —

Timeline

10 Nov 2026 → 1 Jan 2028 · 3 dates

Planning notice published4 days ago
10 Nov 2026, 16:28 GMT
Today
15 Nov 2026
Tender notice expectedin 170 days
4 May 2027, 23:59 BST
Contract starts
1 Jan 2028

Notice history

1 event · 1 release on Find a Tender

Pipeline notice published
10 Nov 2026, 16:28 GMT
UK1

Commercial outcome & contract awards

Pipeline notice

Awards (0): No award published
Contracts (0): No contract published
Bid statistics: No aggregate bid statistics published

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact email

Official documents & specifications (1)

Official links; attachments are not copied

Notices published for this procedure

Pipeline notice planningPipeline noticeUK1Pipeline notice on Find a Tender10 Nov 2026, 16:28 GMT